HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Artificial Intelligence In Consumer Health: Reality, Challenge And Opportunity

Executive Summary

Are self-care apps and digital health wearables touted as powered by AI actually "intelligent"? Currently, no. However, they could be in the future, if regulators can come up with frameworks flexible enough to keep up with adaptive algorithms and machine learning. This article looks at some of the key regulatory issues facing this fast-growing and exciting consumer health market. 

You may also be interested in...



FDA Down-Classifies Another App Linked To Apple Watch

Agency finalizes order allowing sponsors to submit 510(k) applications for photoplethysmograph analysis software less than a month after doing same for another Apple-led app.

PAGB Digital Week, Day 5: Challenges And Opportunities For Digital Self-Care

The final day of PAGB's Digital Week focused on digital self-care and featured sessions on understanding human behavior, the problem of online health misinformation and how best to navigate the new post-COVID reality.

PAGB Digital Week, Day 4: Harnessing The Potential Of Apps For Self-Care

Day four of PAGB's Digital Week saw the association launch its new guidance on mobile health apps, which will help consumer health companies navigate this booming segment. Representatives from J&J, Healthily and Healthy.io then presented delegates with real world examples of health apps in action and debated the future of the sector.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152378

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel